The Effect of Phloroglucinol in Patients With Diarrhea-predominant Irritable Bowel Syndrome: A Randomized, Double-blind, Placebo-controlled Trial.

J Neurogastroenterol Motil · 2020 · PMC6955199 · PMID 31917916

Europe PMC DOI

hedged sentences

0.0560

closest p · 1.1× alpha

0.0560

boldest claim

The sentences

did not reach statistical significanceP = 0.056so close (0.05 < p ≤ 0.1)

Results The proportion of responders during 2-week treatment period tended to be higher in the phloroglucinol group than in the placebo group, although the difference did not reach statistical significance (55.6% vs 30.6%, P = 0.056).

also in 111,027 other papers

showed a trendno p-value reported

The IBS-QOL also showed a trend towards a better efficacy in the phloroglucinol group than placebo group without statistical significances.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.